Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
236 1 |
Ultima descărcare din IBN: 2024-04-01 11:12 |
SM ISO690:2012 TABIRTA, Alisa, BULAI, Marina, CHIHAI, Victoria, ROTAREANU, Anastasia, CÎRÎM, Mihail. Evaluation Of The Clinical-Functional Status In MedicalRehabilitation Of Persons With COVID-19. In: Balneo and PRM Research Journal, 2022, nr. 3(13), p. 34. ISSN 2734-844X. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Balneo and PRM Research Journal | |||||||
Numărul 3(13) / 2022 / ISSN 2734-844X /ISSNe 2734-8458 | |||||||
|
|||||||
Pag. 34-34 | |||||||
|
|||||||
Descarcă PDF | |||||||
Rezumat | |||||||
Introduction: . After COVID -19 infection, most people have a number of symptoms and functional sequelae. [1,2] Physical deconditioning and immobilization greatly affect a person's functional condition. [3] Reduction of post-COVID-19 sequelae and functional recovery is the key vector for treatment managed by the multidisciplinary rehabilitation team. [4] Objectives. Estimation of the clinical-functional status after COVID-19 and analysis of the level of functionality in the medical rehabilitation process. Material and methods. The descriptive study included 124 patients with a duration from the time of infection from 1 month to 18 months, who benefited from complex physiological-functional rehabilitation treatment. At admission and after treatment were assessed: fatigue (on a scale of 0-10 points), dyspnea after the modified Borg category ratio 10 (CR10) scale; musculoskeletal pain after VAS scale 0-10 points (Visual Analogue Scale).Results. After 10-14 days of physiological rehabilitation treatment in the study group, there was a decrease in cases of severe dyspnea (1% at discharge compared to 5, 6% at admission) and an increase in people with mild dyspnea (58, 2% at discharge versus 4,8% at admission). At the same time, after rehabilitation, 4% of people were severely fatigue compared to 41,1% at hospitalization. Severe musculoskeletal pain after rehabilitation treatment persisted in 2% of patients compared to 19,10% at hospitalization, however, moderate musculoskeletal pain. |
|||||||
|